These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2847366)

  • 1. Effects of chronic toluene exposure on central monoamine and peptide receptors and their interactions in the adult male rat.
    von Euler G; Fuxe K; Hansson T; Ogren SO; Agnati LF; Eneroth P; Härfstrand A; Gustafsson JA
    Toxicology; 1988 Nov; 52(1-2):103-26. PubMed ID: 2847366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal interactions between alpha 2-adrenoceptor agonist and neuropeptide Y binding sites in the nucleus tractus solitarius of the rat. A biochemic and autoradiographic analysis.
    Härfstrand A; Fuxe K; Agnati L; Fredholm B
    J Neural Transm; 1989; 75(2):83-99. PubMed ID: 2537374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of toluene treatment in vivo and in vitro on the binding characteristics of [3H]neurotensin in rat striatal membranes.
    von Euler G; Fuxe K; Hansson T; Gustafsson JA
    Toxicology; 1988 Apr; 49(1):149-54. PubMed ID: 2836971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections.
    Masuo Y; Ohtaki T; Masuda Y; Tsuda M; Fujino M
    Brain Res; 1992 Mar; 575(1):113-23. PubMed ID: 1324082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
    Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
    Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic analysis of the distribution of vasoactive intestinal peptide binding sites in the vertebrate central nervous system: a phylogenetic study.
    Dietl MM; Hof PR; Martin JL; Magistretti PJ; Palacios JM
    Brain Res; 1990 Jun; 520(1-2):14-26. PubMed ID: 2169952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in gamma-aminobutyric acid, mu-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens.
    Churchill L; Dilts RP; Kalivas PW
    Brain Res; 1990 Mar; 511(1):41-54. PubMed ID: 2158856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.
    Raghupathi RK; Artymyshyn R; McGonigle P
    Brain Res Mol Brain Res; 1996 Jul; 39(1-2):198-206. PubMed ID: 8804728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic mapping of [mono[125I]iodo-Tyr10, MetO17]vasoactive intestinal peptide binding sites in the rat brain.
    Martin JL; Dietl MM; Hof PR; Palacios JM; Magistretti PJ
    Neuroscience; 1987 Nov; 23(2):539-65. PubMed ID: 3437978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ.
    Keck BJ; Lakoski JM
    Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute exposure to low concentrations of toluene affects dopamine-mediated locomotor activity in the rat.
    von Euler G; Ogren SO; Bondy SC; McKee M; Warner M; Gustafsson JA; Eneroth P; Fuxe K
    Toxicology; 1991 May; 67(3):333-49. PubMed ID: 1828635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Ni YG; Camacho N; Miledi R
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2715-8. PubMed ID: 9122262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent effects of neonatal toluene exposure on regional brain catecholamine levels and turnover in the adult male rat.
    Von Euler G; Fuxe K; Hansson T; Eneroth P; Gustafsson JA
    Toxicology; 1989 Jan; 54(1):1-16. PubMed ID: 2916239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative autoradiographic distribution of [125I]Bolton-Hunter neuropeptide Y receptor binding sites in rat brain. Comparison with [125I]peptide YY receptor sites.
    Martel JC; Fournier A; St Pierre S; Quirion R
    Neuroscience; 1990; 36(1):255-83. PubMed ID: 2170863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors.
    Celani MF; Fuxe K; Agnati LF; Andersson K; Hansson T; Gustafsson JA; Battistini N; Eneroth P
    Toxicol Lett; 1983 Jul; 17(3-4):275-81. PubMed ID: 6623522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.